FDA Inspection 1177107 — Cosmax USA, Corporation

Cosmax USA, Corporation — FEI 3002679704

The FDA completed an inspection of Cosmax USA, Corporation on Jul 22, 2022 in Carteret, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 22, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carteret, NJ (United States)

Citations

IDCFRDescription
360321 CFR 211.160(b)Scientifically sound laboratory controls

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.